Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-16 Sale |
2025-01-17 7:18 pm |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
5,939 | $0.58 | $3,445 | 456,372 (Direct) |
View |
| 2025-01-14 Sale |
2025-01-15 9:16 pm |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
3,253 | $0.66 | $2,147 | 77,728 (Direct) |
View |
| 2024-10-28 Sale |
2024-10-29 4:43 pm |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
1,884 | $1.9 | $3,580 | 60,981 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-07 5:47 pm |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
13,687 | $1.9836 | $27,150 | 50,365 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 5:16 pm |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
3,431 | $2.71 | $9,298 | 361,135 (Direct) |
View |
| 2023-10-26 Sale |
2023-10-27 4:07 pm |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
1,912 | $1.13 | $2,161 | 21,233 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-15 Option Award |
2025-01-17 7:18 pm |
N/A 2035-01-14 |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
343,750 | $0 | 456,372 (Direct) |
View |
| 2025-01-15 Exercise |
2025-01-17 7:18 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
14,583 | $0 | 456,372 (Direct) |
View |
| 2025-01-13 Exercise |
2025-01-15 9:16 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
8,750 | $0 | 77,728 (Direct) |
View |
| 2024-10-25 Exercise |
2024-10-29 4:43 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
6,250 | $0 | 60,981 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-07 5:47 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
50,000 | $0 | 50,365 (Direct) |
View |
| 2024-01-15 Option Award |
2024-01-17 5:16 pm |
N/A 2034-01-14 |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
320,833 | $0 | 361,135 (Direct) |
View |
| 2024-01-13 Exercise |
2024-01-17 5:16 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
8,750 | $0 | 361,135 (Direct) |
View |
| 2023-10-25 Exercise |
2023-10-27 4:07 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
6,250 | $0 | 21,233 (Direct) |
View |
Ownership |
2023-09-07 5:46 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Bala Mohan SVP, Chief Development Officer |
0 | $0 | 378,145 (Direct) |
View |